An exploratory study for therapeutic effects of geranylgeranylacetone on heart failure

Akasaka Takeshi0 个研究点目标入组 160 人开始时间: 2022年10月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. inpatient
•2. patients recerving standard treatment for heart failure in cardiology
•3. patients aged 18 years or older at the time of concent(regardless of gender)
•4. patients who have received sufficient explanation of this study and have voluntarily
•consented by the mselves or their substitute.

•1.patients taking GGA (including over-the-counter drugs contains GGA,such as Selbelle etc) within 1 month before obtaining consent
•2.patients with severe valvular disease, acute myocardial infarction, unstable angina
•3.patients receiving WAON therapy(soothing warm therapy) within 1 month before obtaining consent
•4.patients who is not able to take capsels
•5.patients with serious liver disease distinct from congestion
•6.patients receiving dialysis
•7.pregnant or potentially pregnant women
•8.lactating women
•9.patients with allergies to GGA
•10.patients without the agreement to participate in this study by them or their substitute
•11.patients who evaluated by the principal investigator to be inappropriate as a research subject

发起方

Akasaka Takeshi